Teleflex out of Limerick, PA received U.S. regulatory clearance to bring to market its ARROW VPS G4 Device, a system that combines micro-Doppler ultrasound technology and intravascular ECG to help position the tip of a central catheter, specifically in the lower 1/3 of the superior vena cava and cavo-atrial junction. From the announcement:
The new ARROW VPS G4 Device offers state-of-the-art design and technology, providing easy-to-follow symbols with further enhancements such as statement of final catheter position, improved sterile field capability, and Wi-Fi access to enable integration with hospital data management systems.
“There are more than three million PICCs and two million CVCs placed in the United States each year,” states Paul Molloy, President of the Vascular Division. “The ARROW VPS G4 Device is a reliable and easy-to-use system designed to help reduce complications and reduce patient exposure to radiation. If used on a regular basis, the system can help streamline hospital workflow, providing benefits to the patient, the caregiver and the health care system. This new product introduction complements our full portfolio aimed at making zero complications in vascular access a reality.”
Press release: Teleflex Receives FDA 510(k) Clearance for Next Generation Vascular Positioning System®
